Skip to main content

Call for Late-Breaking Abstracts


For your presentation to be considered, abstract guidelines must be followed as closely as possible. Please ensure that the presenting author completes the abstract submission. Abstracts must be submitted by September 15, 2022, at 5:00 p.m. CST. There will be no deadline extensions.

All abstracts should report original, previously unpublished work and must not have been previously presented elsewhere. Authors will need to justify why their work should be considered a late-breaking submission (i.e., new results became available, new findings were discovered, a new project was completed, etc., in the time period since the original call for abstracts closed). Revisions of previously submitted abstracts will not be accepted unless there is new data or findings that only became available since the time it was originally submitted.

There is no limit on the total number of abstracts submitted by each presenter. However, if one author submits more than one abstract about the same data set, the abstracts should be substantially different. By submitting their work, authors automatically approve the publication of their accepted abstracts in the journal Diagnosis (

Abstract Types

Oral Presentations

Oral presentations will consist of approximately 10 minutes of presentation and 5 minutes of Q&A.  Oral presentations may include work with scientific, education, or practice improvement themes (see further explanations below). Where possible, presentations with a similar theme or focus will be grouped together.

Poster Presentations

Posters may present scientific, education, or practice improvement work. A poster-viewing session will take place for delegates to discuss the posters with their authors.


A presenting author must be available to present the abstract in person at the SIDM2022 conference. All submitters will be notified of their acceptance status at the end of September 2022.

Submission Themes


Scientific abstracts should report the results of the latest original research related to diagnostic error in medicine and must contain quantitative or qualitative data. Each abstract should be 400 words or less, have a descriptive title, and the following four (4) sections:

  • Background
  • Methods
  • Results
  • Conclusion


This may include one (1) table or figure. If table or figure is included, the abstract narrative must be reduced to 350 words.


Education abstracts should describe the results of just-concluded or ongoing educational programs, evaluation of educational programs, learner assessments, or other aspects of improving diagnosis through health professions education. Studies formally addressing pedagogy, assessment, and development of expertise are also invited. While all submissions are welcomed, we especially encourage descriptions of programs that have robust assessment and evaluation methodology. Further, submissions should address challenges to generalizability of the work as well as integration into existing educational structures. Abstracts should be 400 words or less, have a descriptive title, and follow the outline below:

  • Purpose/Problem
  • Description of Program, Assessment, or Study
  • Outcomes
  • Discussion
  • Significance of Findings


This may include one (1) table or figure. If a table or figure is included, the abstract narrative must be reduced to 350 words.

Practice Improvement

Practice Improvement abstracts should describe just-concluded or ongoing work using programs, strategies, tools, or solutions to improve communication or information flow, and/or process performance for clinical providers and patients to reduce harm associated with diagnostic error in diverse delivery systems. Ideally, these should be solutions that can be quickly implemented in routine practice. Programs addressing diagnostic error in medicine that have been piloted or implemented are encouraged.

These abstracts should include information that allows session attendees to evaluate the replicability of such programs at their institutions. This category is intended for descriptive abstracts as well as programs with more rigorous evaluations. Solutions may be related to but not limited to practice management, patient engagement, and/or use of health information technology. Each abstract should be 400 words or less, have a descriptive title, and the following four (4) sections:

  • Statement of Problem
  • Description of the Intervention or Program
  • Findings to Date
  • Lessons Learned


This may include one (1) table or figure. If a table or figure is included, the abstract narrative must be reduced to 350 words or less.

Review Process and Selection Criteria for SIDM2022

Submitted abstracts will be reviewed by experts in diagnostic error; ranked in relation to other submissions within the same category; and rated on the basis of originality, appropriateness of methodology, clarity of presentation, and implications for research, education, or clinical practice. In addition, suitability as a late-breaking abstract (i.e., new results became available, new findings were discovered, a new project was completed, etc., in the time period since the original call for abstracts closed) will also be considered. Submissions in all categories are eligible for either poster or oral presentation; the top-ranked abstract/s will be selected for oral presentations. Each accepted abstract will be clearly labeled “late-breaking” in conference materials.

Abstract Preparation Guidelines for all Presentations

  • Specify all abbreviations in full at the first mention, followed by the abbreviation in parentheses, thereafter abbreviation only should be used.
  • Abstract should be written in English.
  • Check abstract thoroughly for spelling and grammar (will not be amended by conference secretariat).
  • Do not include references.
  • Do not include a header or footer.

All abstract submissions must include:

  • Title:
    • Maximum number of words: 15
  • Track
  • Body of Abstract:
    • Maximum number of words: 400 words. If optional table or figure is added, the maximum number of words for the abstract must be reduced by 50 words.
  • Authors:
    • Principal author should appear first.
    • Include affiliation for each author.

Abstract Submission

Abstracts must be submitted electronically by the presenting author through the online submission site. You will be required to enter:

  • Authors’ names (presenting author contact details - address, telephone and email)
  • Authors’ affiliations
  • Abstract title

By submitting an abstract all authors agree to release the license to the conference organizers and give permission to publish the abstract in the conference handbook, website, application, etc. and in so doing certify that the abstract is original work.

Note: If your abstract does not conform to the guidelines, including if it is over the word limit, it may be returned to the submitting author to revise or rejected.

Conference Registration

All presenters (including poster presenters) will be required to pay for their own conference registrations. It will be assumed that any presenter not registered has withdrawn from the program and their abstract will be removed from the syllabus and schedule.

CME and Conflict of Interest Compliance

  • Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • All presenters are required to disclose any potential conflicts of interest.
  • Presenters must promote improvements or quality in healthcare and not a specific proprietary business or commercial interest.
  • For oral presenters, please include a slide at the beginning of your presentation stating your learning objective(s).
  • For poster presenters, please include a learning objective(s), in easily readable font, on the poster.
  • Educational materials that are part of a CME activity cannot contain any advertising, trade name, trade symbol, or product-group message.
  • Use of product brand names or logos is not permitted.
  • Use of trademarks or registered service marks for any organization without their permission (except for clinical citations) will not be permitted.
  • Use of company slides is not permitted.
  • Recommendations or emphasis must fairly represent and be based on, a reasonable and valid interpretation of the information available on the subject (e.g., "On balance the data support the following ..."). A balanced view of therapeutic options also means that no single product or service is over-represented in the educational activity when other equal but competing products or services are available for inclusion.
  • For slide presentations and print materials, each slide or key teaching point must state the kind of trial that demonstrates the data being discussed. Slides are not required to state, for example, "Level 1 evidence" (although it is acceptable to include it), but slides are required to include a statement, for example, "Systematic review of 35 RCTs..." or "Case-controlled trial..." that supports what is being discussed and presented within each slide. This is a conventional approach in the tradition of evidence-based medicine and may be viewed at the Oxford Centre for Evidence-Based Medicine.
  • Professional references must be cited for educational content.  It is acceptable to list references at the end of a slide presentation or on a single sheet for poster presentations.